Cargando…
Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01
Next‐generation sequencing of AML has identified specific genetic mutations in AML patients. Hematologic Malignancies (HM)‐SCREEN‐Japan 01 is a multicenter study to detect actionable mutations using paraffin‐embedded bone marrow (BM) clot specimens rather than BM fluid in AML patients for whom stand...
Autores principales: | Hosono, Naoko, Chi, SungGi, Yamauchi, Takahiro, Fukushima, Kentaro, Shibayama, Hirohiko, Katagiri, Seiichiro, Gotoh, Akihiko, Eguchi, Motoki, Morishita, Takanobu, Ogasawara, Reiki, Kondo, Takeshi, Yanada, Masamitsu, Yamamoto, Kazuhito, Kobayashi, Tsutomu, Kuroda, Junya, Usuki, Kensuke, Utsu, Yoshikazu, Yoshimitsu, Makoto, Ishitsuka, Kenji, Ono, Takaaki, Takahashi, Naoto, Iyama, Satoshi, Kojima, Kensuke, Nakamura, Yukinori, Fukuhara, Suguru, Izutsu, Koji, Abutani, Hikaru, Yamauchi, Nobuhiko, Yuda, Junichiro, Minami, Yosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154825/ https://www.ncbi.nlm.nih.gov/pubmed/36793248 http://dx.doi.org/10.1111/cas.15746 |
Ejemplares similares
-
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
por: Katagiri, Seiichiro, et al.
Publicado: (2022) -
Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment
por: Ikezoe, Takayuki, et al.
Publicado: (2022) -
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
por: Ikeda, Daisuke, et al.
Publicado: (2022) -
Evaluation of bilateral force deficit in shoulder flexion using a handheld
dynamometer in healthy subjects
por: Shimada, Kensuke, et al.
Publicado: (2017) -
Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)